38 filings
- Disclosure of shares outstanding and voting rights - 07.08.2026AccorVoting rights and capital
- Cellectis Reports Financial Results for the Second Quarter 2026CellectisHalf-year financial report
- Monthly information on share capital and company voting rightsCellectisVoting rights and capital
- Availability of the 2026 Interim Financial ReportAccorHalf-year financial report
- Ipsen S.A. publishes its 2026 Half-Year Report (half-year ended 30 June 2026)Ipsen SAHalf-year financial report
- Press Release: Sanofi’s half-year financial report for 2026SanofiInside information
- Inside Information / News release on accounts, resultsEmeisInside information
- Ipsen provides update on Phase III BOLD trial in biliary atresiaIpsen SAInside information
- Inside Information / Other news releasesInnate PharmaInside information
- Inside Information / Other news releasesInnate PharmaInside information
- Report on Carbios’ liquidity contractCarbiosShare buyback
- Sanofi: Information concerning the total number of voting rights and shares - June 2026SanofiVoting rights and capital
Archive
Filings month by month.
- August 2026431
- July 20262,846
- June 20261,859
- May 20261,961
- April 20262,762
- March 20262,304
- February 20261,744
- January 20262,003
- December 20251,591
- November 20251,756
- October 20252,111
- September 20252,135
- August 20251,165
- July 20252,674
- June 20251,981
- May 20251,866
- April 20252,828
- March 20252,332
- February 20251,771
- January 20252,078